• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[使用新型基质治疗剂(RGTA)治疗带状疱疹神经源性溃疡:一例报告]

[Management of herpes zoster neurotrophic ulcer using a new matrix therapy agent (RGTA): A case report].

作者信息

De Monchy I, Labbé A, Pogorzalek N, Gendron G, M'Garrech M, Kaswin G, Labetoulle M

机构信息

Service d'ophtalmologie, CHU Bicêtre, Assistance publique-Hôpitaux de Paris, 78, avenue du Général-Leclerc, 94270 Le Kremlin-Bicêtre, France.

出版信息

J Fr Ophtalmol. 2012 Mar;35(3):187.e1-6. doi: 10.1016/j.jfo.2011.09.002. Epub 2011 Oct 19.

DOI:10.1016/j.jfo.2011.09.002
PMID:22015067
Abstract

Neurotrophic keratopathy is a potential consequence of herpes simplex virus (HSV) or varicella zoster virus (VZV) infection. The treatment is based on artificial tears and the withdrawal of preserved eye drops or other types of epitheliotoxic topical medicines. Autologous serum or amniotic membrane transplantation may also be used in severe cases, but their cost and safety are still under debate. We report a case of a patient with a history of herpes zoster ophthalmicus, who developed a persistent epithelial ulcer after cataract surgery, with no improvement despite 3 weeks of artificial tears (eight drops per day). A new ophthalmologic solution based on a regenerating agent (RGTA, Cacicol20(®)) was then used, with a dosage of two eye drops per week for 6 weeks. Improvement was observed 1 week later, and complete healing was obtained in less than 3 weeks, with no side effects. This heparin mimetic, which may stimulate extracellular matrix healing, may be a possible alternative therapy to autologous serum or amniotic membrane transplantation in severe neurotrophic ulcer. However, randomized studies are necessary to validate this observation.

摘要

神经营养性角膜病变是单纯疱疹病毒(HSV)或水痘带状疱疹病毒(VZV)感染的潜在后果。治疗方法基于人工泪液以及停用含防腐剂的眼药水或其他类型的上皮毒性局部用药。严重病例中也可使用自体血清或羊膜移植,但它们的成本和安全性仍存在争议。我们报告一例有眼部带状疱疹病史的患者,其在白内障手术后出现持续性上皮溃疡,尽管使用人工泪液(每天八滴)治疗3周仍无改善。随后使用了一种基于再生剂(RGTA,Cacicol20®)的新型眼科溶液,每周滴入两眼各一滴,持续6周。1周后观察到病情改善,不到3周即完全愈合,且无副作用。这种模拟肝素的物质可能刺激细胞外基质愈合,在严重神经营养性溃疡中可能是自体血清或羊膜移植的一种替代治疗方法。然而,需要进行随机研究来验证这一观察结果。

相似文献

1
[Management of herpes zoster neurotrophic ulcer using a new matrix therapy agent (RGTA): A case report].[使用新型基质治疗剂(RGTA)治疗带状疱疹神经源性溃疡:一例报告]
J Fr Ophtalmol. 2012 Mar;35(3):187.e1-6. doi: 10.1016/j.jfo.2011.09.002. Epub 2011 Oct 19.
2
Topical treatment with a new matrix therapy agent (RGTA) for the treatment of corneal neurotrophic ulcers.新型基质治疗剂(RGTA)局部治疗角膜神经营养性溃疡。
Invest Ophthalmol Vis Sci. 2012 Dec 13;53(13):8181-5. doi: 10.1167/iovs.12-10476.
3
Boston keratoprosthesis treatment of herpes zoster neurotrophic keratopathy.波士顿人工角膜治疗带状疱疹性神经营养性角膜病变。
Ophthalmology. 2008 Feb;115(2 Suppl):S21-3. doi: 10.1016/j.ophtha.2007.10.013.
4
Herpes zoster peripheral ulcerative keratitis in patients with the acquired immunodeficiency syndrome.获得性免疫缺陷综合征患者的带状疱疹性周边溃疡性角膜炎
Cornea. 1996 Sep;15(5):446-50.
5
Optic neuritis heralding varicella zoster virus retinitis in a patient with acquired immunodeficiency syndrome.一名获得性免疫缺陷综合征患者中,视神经炎预示着水痘带状疱疹病毒视网膜炎。
Ann Neurol. 1998 Apr;43(4):534-6. doi: 10.1002/ana.410430420.
6
Peripheral corneal ulcers with herpes zoster ophthalmicus.
Am J Ophthalmol. 1978 Nov;86(5):611-4. doi: 10.1016/0002-9394(78)90176-9.
7
Neurotrophic Keratopathy: Therapeutic Approach Using a Novel Matrix Regenerating Agent.神经营养性角膜病变:使用新型基质再生剂的治疗方法。
J Ocul Pharmacol Ther. 2017 Nov;33(9):662-669. doi: 10.1089/jop.2017.0010. Epub 2017 Sep 14.
8
Evaluation and management of herpes zoster ophthalmicus.眼部带状疱疹的评估与管理
Am Fam Physician. 2002 Nov 1;66(9):1723-30.
9
Matrix Regeneration Therapy: A Case Series of Corneal Neurotrophic Ulcers.基质再生疗法:角膜神经营养性溃疡病例系列
Cornea. 2016 Apr;35(4):451-5. doi: 10.1097/ICO.0000000000000759.
10
Healing of resistant corneal neurotrophic ulcers using a matrix regenerating agent.使用基质再生剂治疗顽固性角膜神经营养性溃疡
J Fr Ophtalmol. 2019 Feb;42(2):159-165. doi: 10.1016/j.jfo.2018.05.009. Epub 2018 Dec 17.

引用本文的文献

1
Case Reports for Topical Treatment of Corneal Ulcers with a New Matrix Therapy Agent or RGTA in Dogs.犬角膜溃疡局部治疗用新型基质疗法药物或再生生长因子激活剂的病例报告
Vet Sci. 2019 Dec 13;6(4):103. doi: 10.3390/vetsci6040103.
2
Matrix regeneration agents improve wound healing in non-stressed human corneal epithelial cells.基质再生剂可改善非应激状态下人角膜上皮细胞的伤口愈合。
Eye (Lond). 2018 Apr;32(4):813-819. doi: 10.1038/eye.2017.277. Epub 2017 Dec 22.
3
Corneal matrix repair therapy with the regenerating agent in neurotrophic persistent epithelial defects.
使用再生剂治疗神经营养性持续性角膜上皮缺损的角膜基质修复疗法。
Int J Ophthalmol. 2017 Dec 18;10(12):1935-1939. doi: 10.18240/ijo.2017.12.25. eCollection 2017.
4
RGTA or ReGeneraTing Agents mimic heparan sulfate in regenerative medicine: from concept to curing patients.再生治疗剂(RGTA)或再生剂在再生医学中模拟硫酸乙酰肝素:从概念到治愈患者。
Glycoconj J. 2017 Jun;34(3):325-338. doi: 10.1007/s10719-016-9744-5. Epub 2016 Dec 7.
5
Treatment of Acanthamoeba neurotrophic corneal ulcer with topical matrix therapy.局部基质疗法治疗棘阿米巴滋养体性角膜溃疡
J Ophthalmic Inflamm Infect. 2015 Jun 21;5:18. doi: 10.1186/s12348-015-0048-x. eCollection 2015.
6
A Rapid Response to Matrix Therapy With RGTA in Severe Epidermolysis Bullosa.重症大疱性表皮松解症对含RGTA的基质疗法的快速反应
Eplasty. 2012;12:ic15. Epub 2012 Oct 17.